Biomarkers help tailor diuretic treatment for acute heart failure patients

23:29 EDT 25 May 2019 | News-Medical.net

Adrenomedullin activity predicts which acute heart failure patients are at the greatest risk of death without diuretic treatment post-discharge, according to late breaking research presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology.

More From BioPortfolio on "Biomarkers help tailor diuretic treatment for acute heart failure patients"